@article{article, title = {{A Salvage Autologous Stem Cell Transplant (ASCT2) Induces Superior Overall Survival Following Bortezomib-Containing Re-Induction Therapy for Relapsed Multiple Myeloma (MM): Results from the Myeloma X (Intensive) Trial}}, publisher = {{American Society of Hematology}}, url = {{}}, year = {{2015}}, month = {{12}}, author = {{Cook G and Williams C and Cairns DA and Hockaday A and Cavenagh J and Snowden JA and Parrish C and Yong KL and Cavet J and Hunter H and Bird J et al}}, doi = {{10.1182/blood.v126.23.394.394}}, volume = {{126}}, journal = {{Blood}}, issue = {{23}}, pages = {{394-394}}, note = {{Accessed on 2025/06/22}}}